| 摘要 |
Ophthalmically therapeutic compositions, such as polymeric drug delivery systems, include a therapeutic component that includes a sirtuin-activating agent, such as resveratrol, which, upon delivery to the posterior segment of a mammalian eye, treats ocular conditions. Methods of making and using the present compositions are also described. H:/tzm/Interwoven/NRPortbl/DCC/TZM/5904500_1.DOC - 18/12/13 |
